Editorials

A new kid on the block for acute myeloid leukemia treatment? Homoharringtonine interferes with key pathways in acute myeloid leukemia cells

Marijana Kumerich Chair in Leukaemia and Lymphoma Research, Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2019.234880